Update: New registered manufacturer is publicly announced - Panacea Biotec Ltd becomes the second firm after the Serum Institute of India

With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate.

Panacea Biotect Ltd and the Serum institute of India are two of the companies that have begun the registration process in order to participate. Several companies have inquired about the pilot.

Information about the number and names of manufacturers is confidential unless a firm requests its information to be made public.

For more information about the AMC registration process please contact: amc@gavialliance.org